Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ICMAD Looks To Sway Legislators To Sessions Cosmetics Bill

This article is powered by The Rose Sheet

Executive Summary

With letters to key legislators in the House and Senate, the Independent Cosmetic Manufacturers and Distributors looks to build support for the approach laid out in the Cosmetics Modernization Act of 2015, maintaining that the front-running Personal Care Products Safety Act is a danger to small business.


Related Content

ICMAD Stands By House Cosmetics Bill, But May Be Ready To Negotiate
Trump's Budget Blueprint: Cosmetics Opportunity Or Unhelpful Distraction?
Pending FDA User-Fee Legislation May Be ‘Big Shot’ For Cosmetics Reg Reform
PCPC Statement On Cosmetics Reform Legislation Hints At Potential Compromises
Could Cosmetic Modernization Bill Jumpstart Anti-Aging Skin Care?
Handcrafted Cosmetics Sector Says Exemptions In Reform Bills Are Insufficient
Sen. Alexander Questions FDA's Slow Response To WEN Complaints
Industry Makes Pitch For National Uniformity At Senate HELP Hearing
ICMAD: Small Business Looks To Pull Off Preemption Balancing Act
House Cosmetics Bill Seeks Broad Federal Preemption, Revised 'Cosmetic' Definition





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts